Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine ...Middle East

Novavax's updated JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3 Novavax's JN.1 COVID-19 vaccine would be the only protein-based option available in the U.S. Novavax's filing is aligned with FDA, EMA and WHO global recommendations on vaccine...

Hence then, the article about novavax submits application to u s fda for updated protein based 2024 2025 formula covid 19 vaccine was published today ( Friday 14/06/2024 - 09:12 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine )

Also on site :

• The Middle East war is testing the Gulf’s ambitions to become an AI hub
• Move over, seltzer. Non-carbonated drinks are taking the spotlight
• Man dies in northeast Australia after shark attack